SingletO2 Therapeutics

New Providence, United States

SingletO2 Therapeutics develops new treatments for periodontal disease using singlet oxygen.

$75K raised

Oct 2024

Grant

Biotechnology Health Care Therapeutics

Top Investors

National Science Foundation Commission on Science Innovation and Technology

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about SingletO2 Therapeutics

How much funding has SingletO2 Therapeutics raised?

SingletO2 Therapeutics has raised $75K in total funding. The most recent round was Grant. The last funding was announced in October 2024.

Who are SingletO2 Therapeutics's investors?

SingletO2 Therapeutics's investors include National Science Foundation, Commission on Science, Innovation and Technology.

Where is SingletO2 Therapeutics headquartered?

SingletO2 Therapeutics is headquartered in New Providence, United States.

What does SingletO2 Therapeutics do?

SingletO2 Therapeutics develops new treatments for periodontal disease using singlet oxygen.

What stage is SingletO2 Therapeutics at?

SingletO2 Therapeutics is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 15, 2024.

MLA

"SingletO2 Therapeutics — Funding & Investors." VCBacked, October 15, 2024, https://www.vcbacked.co/company/singleto2-therapeutics. Accessed July 5, 2026.

APA

VCBacked. (2024). SingletO2 Therapeutics — Funding & Investors. Retrieved July 5, 2026, from https://www.vcbacked.co/company/singleto2-therapeutics

Wikipedia (cite web)

{{cite web |title=SingletO2 Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/singleto2-therapeutics |website=VCBacked |access-date=July 5, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 15, 2024.